|
|
||||||||
Eur J Cardiothorac Surg 2002;22:112-117
© 2002 Elsevier Science NL
a Department of Cardiac Surgery, Gasthuisberg University Hospital, Leuven, Belgium
b Klinik für Herzchirurgie, Herzzentrum, Universität Leipzig, Leipzig, Germany
c Klink für Herz- und Gefässchirurgie, Christian-Albrechts Universität Kiel, Kiel, Germany
d Klink für Herzchirurgie, Universitätsklinikum Charité, Berlin, Germany
e Herz- und Kreislaufzentrum, Technische Universität Dresden, Dresden, Germany
f Klinik für Thorax-, Herz- und Gefässchirirgie, Universitätsklinikum Aachen, Aachen, Germany
g Klinik für Thorax-, Herz- und Gefässchirurgie, Medizinische Hochschule Hannover, Hannover, Germany
h Aix Scientifics, Pauwelstrasse 19, Aachen, Germany
Received 17 September 2001; received in revised form 28 January 2002; accepted 15 March 2002.
* Corresponding author. Department of Cardiac Surgery, Gasthuisberg University Hospital, Herestraat 49, KU Leuven, 3000 Leuven, Belgium. Tel.: +32-16-344-260; fax: +32-16-344-616
e-mail: bart.meyns{at}uz.kuleuven.ac.be
| Abstract |
|---|
|
|
|---|
Key Words: Coronary artery bypass grafting Microaxial blood pumps Cardiopulmonary bypass Myocardial support
| 1. Introduction |
|---|
|
|
|---|
The primary objective of this study was to investigate and compare the safety and efficacy aspects in coronary artery bypass grafting (CABG) performed with normothermic CPB and CABG supported with the intracardiac microaxial pump (ICP, Impella, Aachen, Germany).
The secondary objectives are to demonstrate the ability to provide sufficient hemodynamic support and to analyze the inflammatory response.
| 2. Materials and methods |
|---|
|
|
|---|
Table 1 shows the demographic data of the patient groups. Both groups are comparable in demographic variables, number of bypasses performed, and Euroscore predicted mortality.
|
|
The left side support pump was inserted via an introducer on the ascending aorta. The pump was then advanced across the aortic valve on guidance of the differential pressure sensor. Transesophageal echocardiography was used to confirm the position. The right side pump was introduced through a purse-string on the right atrium. The pressure channel at the tip of the cannula allows to confirm the presence of the cannula in the pulmonary artery. In the ICP group, regional ischemia was applied by snaring the target vessel.
2.4. Protocol
Technical ease of introduction and use of the ICP was assessed. Evolution of mean arterial pressure and mixed venous oxygen saturation were assessed during the procedure. Hemolysis (by means of plasma free hemoglobin), liver metabolism (defined by total bilirubin), renal function (defined by serum creatinine), myocardial ischemia (defined by creatine kinase, troponin I), cellular counts and inflammatory response (defined by lymphocyte counts, complement C3 and granulocyte elastase) were assessed preoperatively, perioperatively, on postoperative days 13, at discharge and at 3 months follow-up. A creatine kinase release exceeding three times the upper level of the normal value, with a 10% myocardial fraction, was considered to indicate a perioperative myocardial infarction.
2.5. Statistical analysis
All continuous data are shown with their mean value and standard deviation. The statistical analysis and statistical processing were performed using SAS statistical software (SAS Institute Inc., Cary, NC, USA). Differences between the two groups were analyzed with the Fisher exact test for nominal data and the Wilcoxon test for continuous data. A P-value <0.05 was considered statistically significant.
| 3. Results |
|---|
|
|
|---|
There was no significant difference between the two study arms regarding the pump assistance time (CPB 67.1±22.9 min; ICP 67.7±30.3 min; P=0.88861), the number of grafts (CPB 2.4±0.7; ICP 2.3±0.8) and the number of grafts to the back wall (CFX; both groups n=37). The mean arterial pressure (Fig. 2 ) during pump assistance is significantly different between the groups (CPB 61.0±7.4 mmHg; ICP 69.9±7.5 mmHg; P=0.0001). Flow rates obtained by the ICP depend on the pressure head for the pump and the rotational pump speed (Fig. 3 ). The flow rates achieved during surgery at the highest rotational speed is 4.1±0.6 l/min.
|
|
|
There is no difference in hemolysis as measured by free plasma hemoglobin (Fig. 4 ). However, four patients from the ICP group had a peak value of free plasma hemoglobin exceeding 100 mg/dl. These peak values could not be related to the duration of pump support. In one patient the peak value reached after surgery, on intensive care with normal values during surgery. The three others reached peak values at different moments in time during surgery (they were three out of the ten patients receiving packed blood cell transfusion during surgery).
|
There is no difference in peri and postoperative evolution of serum levels of bilirubin, creatinine, urea and clotting tests. However, there was a significant difference in AT-III levels 2 h post surgery (ICP 60±15, CPB 68±15; P=0.00074).
3.3. Inflammatory response
Inflammatory response parameters (Table 3) are analyzed for patients having CPB (n=94) versus patients supported with ICP only (n=87). Patients who had both approaches, ICP and CPB, were not regarded in this subanalysis. There is no difference in peri and postoperative evolution of granulocytes, leucocytes, monocytes or thrombocytes. The postoperative serum levels of D-dimers and antithrombin III were continuously higher for the CPB group but the differences are not significant. There is a significant difference in granulocyte elastase (P<0.00001) and complement C3 (P=0.008) release in relation to pump support. Both sensitive parameters of inflammatory response were significantly higher in the CPB group as compared to the ICP group.
|
| 4. Discussion |
|---|
|
|
|---|
Unloading of the left heart during coronary occlusions has been shown to be beneficial in animal studies as well as in clinical experience [911,13,14]. It results in reduced myocardial oxygen consumption during the procedure and leads to improved myocardial perfusion and superior myocardial function after the procedure [911]. The need for a right heart support system originates from the initial observation that lifting the heart leads to a kink of the right ventricle [15]. Several surgeons have overcome this problem by manipulation measures such as Trendelenburg position, pericardial suspension stitches and opening of the right pleural cavity. In this study the introduction of the right side pump proved to be the most difficult part. The procedure was inadequate in 12 patients leading to further design changes of the right side catheter; the current right ventricular support system bypass the blood from the right atrium directly into the pulmonary artery avoiding the difficult guidance of the outflow cannula through the right heart. It is placed via standard cannulation of the right atrial appendage and the pulmonary artery and initiated by a quick connection.
Clinical outcome did not differ in both groups. However, the primary endpoint of this study was to evaluate the safety of a new revascularization technique with intravascular blood pumps. The focus of the study was feasibility, hemodynamic performance and hemolysis. Therefore, the study design and the limited number of patients (n=200) allow no clear estimate of the advantages and disadvantages of this technique on clinical outcome. In addition, the inclusion of seven different centers attributes to the variety of the data and emphasizes the learning curve of such a new technology. The only relevant difference in this study is the reduced level of granulocyte elastase and complement C3 release in the ICP group indicating a reduced inflammatory response very similar to the findings in off-pump surgery. This reduction in inflammatory parameters did not result in any clinical effect. A reduced inflammatory response can be explained by the reduction of foreign material contact area. The patient's own lungs are used for oxygenation and no cardiotomy suction or venting catheter is used. The finding that hemodilution is less pronounced in the ICP group might as well be of clinical interest.
The occasional occurrence of organ dysfunction and multiple organ failure associated with the use of CPB is evoked by the CPB-related inflammatory response [16]. Revascularization with mechanical support is not only similar to beating heart surgery in the reduction of inflammatory response, it is also technically very much alike. Therefore, it requires the same technical demands and entangles the same dangers as off-pump surgery. Having shown that the procedure is feasible and that inflammatory response is reduced does not delineate the correct indications for this technology. It is obvious that a great number of patients can undergo off-pump surgery without the need of any support. The unloading capacities of the intracardiac blood pumps can, however, play a crucial role in patients where hemodynamic support is preferred and especially in patients with reduced ventricular function.
| Acknowledgments |
|---|
| Footnotes |
|---|
| Appendix A. Conference discussion |
|---|
|
|
|---|
Dr Meyns: No. I must be very honest, I have the same surprise as you have. I expect that this bleeding should be less of a problem, but it turned out that there were more revisions for bleeding; although the difference was not significant, there were more revisions for bleeding, yes.
Dr A. Mazzucco (Verona, Italy): Referring to your final statement, are you actually telling us that use of this means of circulatory assistance is no longer to be your recommendation? I mean, are you going to stop using this machine?
Dr Meyns: Well, as a matter of fact we are doing more than 90% of our cases completely off-pump surgery. So the question is, where do you have the place of support of beating heart surgery? I personally believe that the unloading of the left ventricle might be critical in patients who have a bad ventricular function, but in the routine cases with a normal ventricular function, I think that off-pump surgery is the first choice.
Dr M. Irarrazaval (Santiago, Chile): You are planning to use this as support for off-pump cases?, because you are requiring a substantial manipulation of the aorta by introducing the pump through the aorta and the aortic valve, and you still have to do the proximals. So it will only be in a very selective group of patients where supposedly "off-pump plus" is more beneficial. Those that have probably a stronger need for a decreasing inflammatory response will be likely candidates. Is that your idea?
Dr Meyns: Well, as I just said, I think that the first choice in the non-emergent CABG patients should be complete off-pump surgery without any support, however, in patients where you have got problems with a bad ventricle or ongoing ischemia, I think that these pumps can help. But I agree completely, you still have the manipulation of the aorta, and in terms of the advantages of off-pump for stroke, this procedure will not give you any advantage.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Bierbach, M. Meier, W. Kasper-Konig, A. Heimann, B. Alessandri, G. Horstick, H. Oelert, and O. Kempski Emboli Formation Rather Than Inflammatory Mediators Are Responsible for Increased Cerebral Water Content After Conventional and Assisted Beating-Heart Myocardial Revascularization in a Porcine Model Stroke, January 1, 2008; 39(1): 213 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Catena, F. Milazzo, M. Merli, R. Paino, A. Garatti, T. Colombo, and E. Vitali Echocardiographic evaluation of patients receiving a new left ventricular assist device: the Impella(R) recover 100 Eur J Echocardiogr, December 1, 2004; 5(6): 430 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boening, C. Friedrich, D. Caliebe, and J. Cremer Efficacy of intracardiac right ventricular microaxial pump support during beating heart surgery Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 495 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Reesink, A. L. Dekker, V. van Ommen, C. Soemers, G. G. Geskes, F. H. van der Veen, and J. G. Maessen Miniature Intracardiac Assist Device Provides More Effective Cardiac Unloading and Circulatory Support During Severe Left Heart Failure Than Intraaortic Balloon Pumping Chest, September 1, 2004; 126(3): 896 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schmidt, J. Siefker, S. Spiliopoulos, and O. Dapunt New experience with the paracardial right ventricular axial flow micropump impella elect 600 Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 307 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Meyns, J. Stolinski, V. Leunens, E. Verbeken, and W. Flameng Left ventricular support by Catheter-Mountedaxial flow pump reduces infarct size J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1087 - 1095. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |